Gestational Trophoblastic Disease (GTD) is when tumor(s) form in the uterus during pregnancy. These tumors are made up of trophoblast cells. Trophoblasts are cells that are made during the first stage of pregnancy. They provide nutrients for the embryo and become part of the placenta. The tumors can be cancerous (malignant) or non-cancerous (benign). Another name for GTD is Gestational Trophoblastic Neoplasia (GTN).
Your risk for GTD may be higher if you:
The signs of GTD can be the same as the signs of a miscarriage (the loss of a pregnancy). There also may be no signs and it may seem to be a normal pregnancy.
Some of the symptoms of GTD during pregnancy are:
If you or your provider thinks you have GTD, they will look at your health history and check your pelvis. They may also do an ultrasound, test your blood and urine, and check for levels of certain tumor markers.
If GTD is cancerous, you will need treatment. To plan treatment, the tumor is given a stage and a score. The stages of the tumor are 1 to 4 (I to IV). Stage 1 means the disease is only in the uterus and stage 4 means the tumor has spread (metastasized).
The score helps figure out your overall risk and which treatment may be best. The score is a number given based on certain factors, such as:
GTD is often treated with surgery which helps find, stage, and remove as much of the tumor as possible. Some of the common types of surgery are:
Chemotherapy may also be used to kill cancer cells.
This article is a basic guide to GTD. You can learn more about GTD by visiting:
Surgical Procedures: Surgery and Staging for Gestational Trophoblastic Neoplasia (GTN)
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania